Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate InspireMD, Inc. before investing.

In this article, we go over a few key elements for understanding InspireMD, Inc.’s stock price such as:

• InspireMD, Inc.’s current stock price and volume
• Why InspireMD, Inc.’s stock price changed recently
• Upgrades and downgrades for NSPR from analysts
• NSPR’s stock price momentum as measured by its relative strength

About InspireMD, Inc. (NSPR)

Before we jump into InspireMD, Inc.’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Want to learn more about InspireMD, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about InspireMD, Inc..

InspireMD, Inc.’s Stock Price as of Market Close

As of May 04, 2026, 9:45 AM, CST, InspireMD, Inc.’s stock price was $1.120.

InspireMD, Inc. is down 2.61% from its previous closing price of $1.150.

During the last market session, InspireMD, Inc.’s stock traded between $1.040 and $1.130. Currently, there are approximately 82.37 million shares outstanding for InspireMD, Inc..

InspireMD, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

InspireMD, Inc. Stock Price History

InspireMD, Inc.’s (NSPR) price is currently down 5.08% so far this month.

During the month of May, InspireMD, Inc.’s stock price has reached a high of $1.180 and a low of $1.040.

Over the last year, InspireMD, Inc. has hit prices as high as $2.932 and as low as $1.120. Year to date, InspireMD, Inc.’s stock is down 37.08%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused InspireMD, Inc. Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of May 01, 2026, there was 1 analyst who downgraded InspireMD, Inc.’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate InspireMD, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on InspireMD, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

InspireMD, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about InspireMD, Inc. (NSPR) by visiting AAII Stock Evaluator.

Relative Price Strength of InspireMD, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of May 01, 2026, InspireMD, Inc. has a weighted four-quarter relative price strength of -24.70%, which translates to a Momentum Score of 8 and is considered to be Very Weak.

Want to learn more about how InspireMD, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

InspireMD, Inc. Stock Price: Bottom Line

As of May 4, 2026, InspireMD, Inc.’s stock price is $1.120, which is down 2.61% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like InspireMD, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.